Form 4: MACOM SVP Executes Pre-Arranged Stock Option Exercise and Share Sales
Insider Transaction Report
MACOM Technology Solutions Holdings' SVP of Global Sales, Donghyun Thomas Hwang, completed a series of stock option exercises and subsequent share sales totaling 5,000 shares under a Rule 10b5-1 trading plan.
Summary
- Donghyun Thomas Hwang, SVP, Global Sales of MACOM Technology Solutions Holdings, Inc. (MTSI), reported transactions on July 22, 2025.
- Exercised stock options to acquire 5,000 shares of Common Stock at an exercise price of $16.06 per share.
- Simultaneously sold 5,000 shares of Common Stock in multiple transactions at weighted average prices ranging from $135.85 to $139.89.
- The transactions were executed pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on August 25, 2023.
- Following these transactions, the Reporting Person beneficially owns 30,779 shares of Common Stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral. While an insider sale might typically be viewed negatively, the fact that it was conducted under a pre-arranged Rule 10b5-1 plan mitigates any negative signal, as it indicates the sale was not based on new, undisclosed information.
Positives
- The insider exercised stock options, indicating the options were in-the-money and providing a financial benefit to the executive.
- Shares were sold at significantly higher prices (ranging from $135.85 to $139.89) compared to the exercise price ($16.06), demonstrating a substantial gain for the executive.
Negatives
- An insider sold a significant number of shares (5,000 shares), which could be perceived negatively by some investors, although the sale was pre-planned under a 10b5-1 arrangement.
Future Outlook
NA
Industry Context
This filing is a standard insider transaction report (Form 4) and does not provide information relevant to broader industry trends or competitive dynamics. It solely details an executive's pre-planned stock transactions.
Stakeholder Impact
- Shareholders: The sale of shares by an executive, even if pre-planned, slightly increases the float and could be perceived as the executive diversifying their holdings. However, the pre-planned nature under Rule 10b5-1 reduces the likelihood of it being interpreted as a lack of confidence in the company's future.
Key Dates
| Date | Description |
|---|---|
| 02/16/2021 | Date the stock option became exercisable. |
| 08/25/2023 | Date the Rule 10b5-1 sales plan was adopted by the Reporting Person. |
| 07/22/2025 | Date of the reported stock option exercise and share sales transactions. |
| 07/24/2025 | Date the Form 4 filing was signed. |
| 11/06/2025 | Expiration date of the stock option. |
Recommendation
holdThe reported transactions are routine insider sales executed under a pre-arranged 10b5-1 plan. These types of transactions are generally not indicative of new material information about the company's performance or outlook and therefore do not typically warrant a change in investment recommendation. Investors should continue to evaluate the company based on its fundamental financial performance and strategic initiatives.
Keywords
MACOM Technology Solutions Holdings, MTSI, Insider Trading, Form 4, Stock Option Exercise, Share Sale, 10b5-1 Plan, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.